Roivant Sciences Ltd.
ROIV NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 6, 2026
ET
EPS Est.
-0.30
EPS Actual
-0.33
Revenue Est.
$2.1M
Revenue Actual
$1.4M
Next Earnings Report Date unconfirmed
Date
Nov 9, 2026 · Mon
Time
Pre-market
Fiscal Period
FY2026 Q2
EPS Est.
-0.41
Revenue Est.
$3.3M
Company Overview
Roivant Sciences Ltd. (ticker ROIV) is listed on NASDAQ with a market cap of about $26.22B. Its next earnings report (FY2026 Q2) is expected on Nov 9, 2026 (ET), Pre-market (date pending company confirmation), with consensus EPS of -0.41. In the last 15 reported quarters, EPS beat consensus estimates 9 times.
Actual EPS TrendRecently15Term · Feb 13, 2023 → Aug 6, 2026
Feb 13, 2023Range: -0.49 ~ 0.12Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | -0.30 | -0.33 | $2.1M | $1.4M |
| May 20, 2026 | -- | -0.29 | -0.28 | $3.4M | $2.5M |
| Feb 6, 2026 | -- | -0.30 | Above forecast↑-0.24 | $5.1M | $2M |
| Nov 10, 2025 | -- | -0.32 | Above forecast↑-0.20 | $5.6M | $1.6M |
| Aug 11, 2025 | -- | -0.25 | -0.25 | $7.3M | $2.2M |
| May 29, 2025 | -- | -0.26 | -0.29 | $54.1M | $7.6M |
| Feb 10, 2025 | -- | -0.25 | -0.23 | $5M | $9M |
| Nov 12, 2024 | -- | -0.25 | Below forecast↓-0.29 | $45.9M | $4.5M |
| Aug 8, 2024 | -- | -0.24 | Above forecast↑0.12 | $30.7M | $55.1M |
| May 30, 2024 | -- | -0.26 | -0.23 | $31M | $28.9M |
| Feb 13, 2024 | -- | -0.31 | Above forecast↑-0.21 | $31.8M | $37.1M |
| Nov 13, 2023 | -- | -0.28 | -0.26 | $27.1M | $37.1M |
| Aug 14, 2023 | -- | -0.30 | Below forecast↓-0.38 | $24.5M | $21.6M |
| Jun 28, 2023 | -- | -0.41 | Above forecast↑-0.20 | $18.2M | $27.4M |
| Feb 13, 2023 | -- | -0.36 | Below forecast↓-0.49 | $14.8M | $17.1M |
Original Filings (SEC)
10-Q2026-08-06 ↗
8-K2026-08-06 ↗
10-K2026-05-20 ↗
8-K2026-05-20 ↗
8-K2026-04-02 ↗
8-K2026-03-03 ↗
8-K2026-03-03 ↗
10-Q2026-02-06 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
